Harvard Bioscience, Inc. (HBIO) vs Microbot Medical Inc. (MBOT)
- Harvard Bioscience, Inc. HBIO 8.09 −2.65%
- Microbot Medical Inc. MBOT 0.95 0.00%
Harvard Bioscience, Inc. and Microbot Medical Inc. are both Medical Instruments & Supplies companies. Microbot Medical Inc. is the larger, with a market value of $63.8M against $37.8M — 1.7× the size. Harvard Bioscience, Inc. grew revenue faster over the last twelve months: −1.06% against −59.1%. Harvard Bioscience, Inc. has the higher net margin (−11.9% vs −3,955.2%) and the higher return on invested capital (−0.41% vs −850.5%). Across the 19 metrics below, Harvard Bioscience, Inc. leads on 10 and Microbot Medical Inc. on 9.
Valuation
Profitability
| Metric | HBIO | MBOT | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 58.16% | (166.30%) | 54.29% |
| Operating margin | (0.28%) | (4,480.03%) | 1.07% |
| Net margin | (11.86%) | (3,955.22%) | (1.61%) |
| Free cash flow margin | (2.09%) | (4,340.11%) | 1.08% |
| Return on equity | (89.95%) | (32.91%) | (1.32%) |
| Return on assets | (13.32%) | (30.68%) | 0.00% |
| Return on invested capital | (0.41%) | (850.51%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack